Management of pediatric epilepsy requires complex coordination of care. We hypothesized that an improved seizure management care plan would reduce health care utilization and improve outcomes. The authors conducted a cohort study with historical controls of 120 epilepsy patients before and after implementation of a ''Seizure Action Plan.'' The authors evaluated for differences in health care utilization including emergency department visits, hospitalizations, clinic visits, telephone calls, and the percentage of emergency department visits that resulted in hospitalization in patients who did or did not have a Seizure Action Plan. The authors found that there was no decrease in these measures of health care utilization, and in fact the number of follow-up clinic visits was increased in the group with Seizure Action Plans (4.2 vs 3.3, P ¼ .006). However, the study was underpowered to detect smaller differences. This study suggests that pediatric epilepsy quality improvement measures may require alternative approaches to reduce health care utilization and improve outcomes.
Management of a child presenting with seizures is a complex process involving medical, social, and educational components. The process involves acute medical care, education of the family about medications, instructions for what to do if there is a seizure, implementation of potentially complicated medication regimens, and instructions for follow-up. Families are often worried and upset when their child is admitted to the hospital, and education and instructions for treatment may not always be correctly understood. Management of epilepsy and other chronic conditions falls heavily on the patient/family and their ability to adhere to medication regimens and understand their disease, including the need to understand potentially complicated plans in case of breakthrough seizures. 1 However, physicians may have unrealistic expectations that patients and families have adequate ability and resources to assume responsibility for management of their disease. 2 Improved care for pediatric epilepsy patients, even in the absence of novel therapies, offers a potential for improving health outcomes and reducing health care utilization. Unexpected readmissions for seizures are the fourth most common reason for readmissions at children's hospitals. 3 Increased education of patients and families has been shown to improve understanding of epilepsy and appropriate antiepileptic medication use. 4 Certain strategies such as prehospital use of intranasal midazolam for a prolonged breakthrough seizure have been demonstrated to reduce hospital admissions. 5 Recent Cochrane reviews 6,7 on patients with chronic medical conditions have concluded that patient/family-centered education programs can lead to improvements in ratings of health and symptoms, with reductions in hospital admissions. For patients with epilepsy, studies have shown that educational programs significantly improved self-management behaviors. 8 However, there are contrary examples; for example, use of Asthma Action Plans did not decrease frequency of emergency department visits and hospitalizations. 9 These findings led us to consider whether a detailed plan for children with epilepsy and their families might reduce health care utilization. The authors hypothesized that a written ''Seizure Action Plan'' would minimize confusion about when to seek health care for seizures; reduce emergency department visits; and reduce in-patient admissions for seizure exacerbations. The Seizure Action Plan would include a list of current antiepileptic medications and their dosages, instructions for use of rescue medications when necessary, instructions for breakthrough seizures, and a specific follow-up plan.
The authors' goal was to provide families and patients with clear instructions that would be readily available to them. The authors studied whether implementation of Seizure Action Plans was associated with a change in the number of emergency department visits and subsequent admissions for seizures, and decreased need for families to contact us with questions.
Methods
This study was approved by the Institutional Review Boards for the University of Utah and for Primary Children's Hospital. The authors performed a cohort study with historical controls of patients with seizures before and after implementation of a Seizure Action Plan. The study was performed at Primary Children's Hospital, which provides primary pediatric care for the urban Wasatch Front region, and is also the sole tertiary children's hospital within a 5 state catchment area for patients from Utah, Wyoming, Idaho, Nevada and Montana. Patients were identified from the Electronic Data Warehouse maintained by Primary Children's Hospital and Intermountain Healthcare, using a computerized search of International Classification of Disease, 9th Edition, Clinical Modification (ICD-9-CM, referred to subsequently as ICD-9) diagnosis codes, and confirmed by manual chart review. A total of 120 patients were analyzed; 60 consecutive patients prior to implementation of the Seizure Action Plan from January 1, 2007, through December 31, 2008; and 60 consecutive patients after implementation of the Seizure Action Plan from January 1, 2010, through December 31, 2011. Each patient was followed for outcomes for 18 months after the index presentation. There was no overlap of patients in the Seizure Action Plan and no Seizure Action Plan groups.
Patients were included in the study if they were admitted to Primary Children's Hospital with a seizure during the study time period; and had a discharge diagnosis of seizure or epilepsy (ICD-9 345.xx or 780.xx). Diagnosis was also confirmed at the time of chart review. The timeframe dates for controls (no Seizure Action Plan, ''nSAP'') group was 1/2007-12/2008; and was 1/2010-12/2011 for the Seizure Action Plan group. Patients were excluded from the study for febrile seizures, seizures provoked by illness or trauma, nonepileptogenic seizures, patients admitted electively for video electroencephalography monitoring, patients with epilepsy admitted for diagnostic evaluation solely, and patients who underwent epilepsy surgery during the study period.
The Seizure Action Plan was designed to provide families and patients with information that might be forgotten or difficult to remember, and that would be helpful in a situation of breakthrough seizures or for determining timing of follow-up ( Figure 1 ). The template for the Seizure Action Plan, which included name and date of birth, was automatically generated by the electronic medical record system, and patient-specific details were filled out by the clinician. Seizure Action Plans were discussed either one-on-one with a family, or sometimes in a larger group of medical personnel, at the time of discharge. Seizure Action Plan introduction to families was not scripted; and discussion of Seizure Action Plans at follow-up clinic visits was left to the discretion of the individual clinician. For the analyses included in this manuscript, only Seizure Action Plans used for hospitalized patients were included. Seizure Action Plans for patients who presented initially in the outpatient setting were not included to maintain a potentially less heterogeneous population for analysis. Discussion about the Seizure Action Plan in follow-up was left to the discretion of the clinician.
Data collected included demographic data including age, gender, ethnicity, and diagnosis; and outcomes data including the number of emergency department visits, number of hospitalizations for seizures, number of pediatric neurology follow-up clinic visits, number of phone calls to the pediatric neurology offices which was recorded as the number of ''Message Logs'' entered into the electronic medical record (message logs are the nurse-entered record of phone calls), length of index hospitalization and number of antiepileptic drugs at discharge. Outcomes data were collected for each patient for the 18-month period following the index admission. Data were managed using Research Electronic Data Capture hosted at the University of Utah. 10 
Statistical Analysis
Deidentified patient data were entered into the Research Electronic Data Capture database, including demographic information, number of antiepileptic drugs, number of emergency department visits, number of neurology clinic follow-up visits, number of phone calls to the pediatric neurology offices, and number of hospitalizations for seizures. Comparison was made of outcomes from patients who did not receive a Seizure Action Plan, to patients who did receive one. Descriptive statistics were used to characterize the study cohort. The 2-proportion z-test was used to calculate P values of demographic data. Wilcoxon rank-sum tests were used to compare outcomes; P values were 2-sided. The authors used SAS University Edition (SAS Institute, Inc, Cary, NC) for analyses.
Results
The total study cohort of 120 patients included 60 control patients from 2007-2008, prior to Seizure Action Plan implementation (the nSAP group), and 60 patients from 2010-2011, after Seizure Action Plan implementation (SAP group) ( Table 1 ). In the SAP cohort there were more males (P ¼ .029) and a higher percentage of children who were on 4 or more antiepileptic drugs (P ¼ .028). Otherwise demographics of the 2 cohorts were similar, including age, ethnicity, length of hospitalization, and discharge diagnosis.
The Seizure Action Plan included a list of current antiepileptic drugs and dosages, instructions for use of rescue medications when necessary, instructions for break-through seizures, and a specific follow-up plan (Figure 1 ). To determine whether use of a Seizure Action Plan reduced health care utilization the authors measured several outcomes, including number of emergency department visits, number of hospital admissions, number of pediatric neurology clinic visits, number of phone calls to the pediatric neurology offices (Figure 2) , and the percentage of emergency department visits that resulted in hospitalization ( Figure 3 ). There were no statistically significant differences in these outcomes between the SAP and nSAP groups ( Table 2) , except that the number of follow-up clinic visits was increased in the group with Seizure Action Plans (4.2 versus 3.3, P ¼ .006).
Because of the difference in baseline demographics between the SAP and nSAP groups, with more Seizure Action Plan patients on 4 or more antiepileptic drugs, the authors performed a subgroup analysis on the 59 nSAP patients compared to the 53 SAP patients who were on fewer than 4 antiepileptic drugs (shown in Table 2 ). In this subgroup analysis there also were no significant differences identified between the SAP and nSAP groups. Of note, the number of males compared to females, which showed a statistically significant difference in the original analysis, was not significant in the subgroup analysis.
Discussion
The authors found that a Seizure Action Plan had no effect in decreasing health care utilization in pediatric epilepsy patients. The authors did not find any statistically significant decreases in emergency department utilization, hospital admissions, or telephone messages between the 2 groups. In fact, the authors observed that the number of follow-up clinic visits was increased in the group with Seizure Action Plans (4.2 versus 3.3, P ¼ .006). Nor did the authors find a difference in the percentage of emergency department visits that resulted in hospitalization. This study is one of the first that the authors are aware of to attempt to improve pediatric epilepsy patient care by reducing health care utilization. 11 The authors compared different outcome measures in patients with epilepsy who did or did not have a Seizure Action Plan. In the comparison between groups there was no decrease in utilization in patients who had a Seizure Action Plan. For example, the number of emergency department visits in the nSAP group was 2.5 visits, compared to 3 in the SAP group. Since the authors found a statistically significant higher percentage of Seizure Action Plan patients who were taking 4 or more antiepileptic medications (P ¼ .028), the authors also performed a subgroup analysis of the 2 groups for those patients on fewer than 4 antiepileptic medications. Even for the subgroup analysis there was no decrease in utilization by the SAP group. For example, clinic visits were 3.4 in the nSAP group and 4 in the SAP group.
Pediatric epilepsy patients have significant medical costs, 12 and there is significant variation across institutions in how care for these patients is delivered. 13 Some studies have shown that increased education can improve understanding of epilepsy 4 and that lay-education programs can improve health and reduce hospitalizations. 2, 3 Interestingly, however, these findings mirror a Joint Commission study of Asthma Action Plans, in which there was the unexpected finding that implementation of Asthma Action Plans did not decrease frequency of emergency department visits and hospitalizations. 9 Other studies of pediatric asthma patients have found that adolescent patients or patients with public insurance had higher readmission rates. 14 Thus, there may be unexpected and/or unrecognized clinical and social factors to uncover to design methods to reduce epilepsy health care utilization.
Limitations to this study include that it was conducted retrospectively; and that the patient cohorts were collected during different time epochs. There was a potential bias in that patients in the control (nSAP) group were on fewer overall medications, suggesting that the patients in the nSAP group had less severe epilepsy. However, even when the authors performed a subgroup analysis consisting of only patients on 3 or fewer antiepileptic drugs, the authors' results still showed no difference in outcomes between SAP and nSAP groups. Furthermore, a Fisher's exact test comparing the proportion of patients on 3 or more antiepileptic drugs versus 2 or fewer, in the SAP and nSAP, shows no statistical difference (2-tailed P ¼ .25).
It is possible that the authors have not identified the appropriate outcome measures, and that emergency department visits and hospitalizations are not the best reflections of Seizure Action Plan efficacy. Also, this cohort of 60 patients and a follow-up of 18 months may not have been sufficient to detect more subtle differences, and the authors' post hoc power analysis revealed a power of only 3-7%. Furthermore, examining hospital admissions, if the authors assumed an 80% power and significance level of 5%, the effect size is only 0.14 (Cohen's d), indicating near complete overlap of the SAP and nSAP groups. Thus, this work provides important direction for future research, suggesting that significantly larger patient cohorts will be necessary.
This study did not address whether there was improved education as a result of implementation of the Seizure Action Plan. While assumed to be true, simply providing the Seizure Action Plan document may not have resulted in ''adequate'' education to affect outcomes. Seizure Action Plans were not discussed in a standardized fashion when introduced to families; and discussion of Seizure Action Plans at follow-up clinic visits was left to the discretion of the individual clinician. This variability could potentially obscure the utility of Seizure Action Plans.
In conclusion, the authors found no significant change in health care utilization following the implementation of the Seizure Action Plan. Potential future studies to reduce pediatric epilepsy health care utilization could include a more standardized provision of the Seizure Action Plan; changes in the format (for example, larger fonts or uses of bright colors) of the Seizure Action Plan; or inclusion of online links to information on epilepsy. For example, the authors have developed a ''Medical Home Portal'' that provides online information for families on commonly diagnosed neurological conditions including epilepsy. 15 Another approach for a revised Seizure Action Plan might include an explicit flow diagram, instructing parents to call the on-call provider for any seizure. While this would likely result in an increase in phone calls, the authors could determine if this intervention might reduce emergency department and admission rates. Other Seizure Action Plans have also been developed, for example by the Epilepsy Foundation 16 and by many school districts; but their efficacy has not been evaluated. Future studies could also examine family perception of complexity of disease management, and on perceived stress associated with the diagnosis of epilepsy and management. Studies such as these can lead toward identification of factors necessary to improve pediatric epilepsy patient health. Numbers (mean; median in parentheses) (as displayed in Figures 2 and 3) for health care utilization before and after implementation of seizure action plan are provided. Subgroup analysis included only patients on 3 or fewer antiepileptic drugs (AEDs). Outcomes and corresponding P value shown.
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